Deals
Bausch + Lomb Owes Ousted CEO About $75 Million In Cash, Not In Its Quarterly Results
The payout and an $85 million acquisition draw on cash as the parent's CEO runs the eye-health company on an interim basis.
BLCO
Bausch + Lomb (BLCO) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Bausch + Lomb Director Nathalie Bernier Resigns, Weeks After CEO Brent Saunders Left
Her exit comes with accelerated vesting of unvested 2026 share units, tied to a mutual release, and the board does not plan to fill her seat.
Earnings
Bausch + Lomb Posts $32 Million Quarterly Profit, Raises Revenue And Adjusted EBITDA Outlook
Revenue rose 7% to $1.375 billion as all three segments grew, and the eye health company lifted its 2026 guidance.
SEC Filings
Bausch + Lomb CEO Brent Saunders Leaves With $75.5 Million Cash Payout; Parent's Chief Steps In
Interim CEO Thomas Appio also runs Bausch Health, and both companies expect to raise full-year adjusted EBITDA guidance.